Dow Down 0.05% Nasdaq Up 0.26%

Hyperion Therapeutics, Inc. (HPTX)

-NMS
24.40 Up 0.42(1.75%) 1:28PM EDT - Nasdaq Real Time Price
Prev Close:23.98
Open:23.94
Bid:24.25 x 100
Ask:24.38 x 100
1y Target Est:39.40
Beta:1.811
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:23.73 - 24.40
52wk Range:18.97 - 32.98
Volume:16,876
Avg Vol (3m):133,116
Market Cap:502.57M
P/E (ttm):19.74
EPS (ttm):1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXUp 1.75%502.57M
ALXNUp 1.50%33.42B
CPIXUp 2.78%90.87M
SLXPDown 0.66%10.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.53
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback